Dr. Ludwin Monz becomes CEO of Carl Zeiss Meditec
(Thomson Reuters ONE) -
Carl Zeiss Meditec AG / Dr. Ludwin Monz becomes CEO of Carl Zeiss Meditec processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
With effect from the end of today's Annual General Meeting, Dr. Ludwin Monz is
the new CEO of Carl Zeiss Meditec AG and as announced on 18 January follows Dr.
Michael Kaschke, who resumes as Chairman of the company's Supervisory Board
JENA - 04 March 2010
Dr. Ludwin Monz is the new CEO of Carl Zeiss Meditec. He takes over from Dr.
Michael Kaschke. At today's Annual General Meeting, Kaschke was elected back to
the Supervisory Board and was appointed its Chairman in the subsequent
Supervisory Board meeting.
"I am looking forward to the new task and will continue the path the company has
taken towards sustainable growth", explains Dr. Ludwin Monz, CEO of Carl Zeiss
Meditec AG, continuing: "Customer-oriented innovation, excellent service and
expansion into new markets as part of our corporate RACE programme are clearly
the three most important strategic initiatives for the coming months."
Dr. Ludwin Monz has been a member of Carl Zeiss Meditec AG's Management Board
since October 2007 and is responsible for the largest strategic business unit,
Ophthalmological Systems. Prior to this he headed up the Microsurgery strategic
business unit for over six years. During this time he developed this department
into a growing and highly profitable part of the company. Numerous innovative
products were launched on the market under his leadership. With a doctorate in
physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in
medical technology since 2000. In addition to various R&D positions, Dr. Ludwin
Monz has worked in numerous key roles within the Group.
"Having Dr. Ludwin Monz as our new CEO has allowed us to win a successor known
for innovation and growth from our own ranks. With ten years of expertise in
medical technology he knows the company, its customers and their needs and Carl
Zeiss Meditec's energy and potential. I know that Carl Zeiss Meditec is in
excellent hands with its current Management Board team and look forward to
supporting the company again in the future as Supervisory Board Chairman", says
Dr. Michael Kaschke, Supervisory Board Chairman of Carl Zeiss Meditec AG.
______________________________________________________________________________
Press contacts:
Eva Sesselmann
Corporate Communications
Carl Zeiss Meditec AG
07745 Jena, Germany
Phone: +49 3641 220-331
Fax: +49 3641 220-112
E-mail:
press(at)meditec.zeiss.com
Patrick Kofler
Investor Relations
Carl Zeiss Meditec AG
07745 Jena, Germany
Phone: +49 3641 220-106
Fax: +49 3641 220-117
E-mail:
investors(at)meditec.zeiss.com
[HUG#1390821]
--- End of Message ---
Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany
WKN: 531370;ISIN: DE0005313704;Index:TecDAX,Prime All Share,TECH All Share;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.03.2010 - 08:41 Uhr
Sprache: Deutsch
News-ID 1010746
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Jena
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 61 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dr. Ludwin Monz becomes CEO of Carl Zeiss Meditec
"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
